DNMT3A and neoplasm: The genetic alterations in 12 PDX specimens suggest persistence of TET2 and DNMT3A loss during tumor passaging, but RHOAG17V showed more variations with disappearance in some PDX models and re‐emergence that follows TET2 loss in some after several passages, indicating more dynamic clonal selection.